Author

Harri Mustonen 1

1 Helsinki University, Biomedicum, Helsinki, Finland

BILE DUCT INFLAMMATION ASSESSED BY BILIARY CALPROTECTIN AND NEUTROPHILS CORRELATES WITH RISK OF BILIARY DYSPLASIA AND CHOLANGIOCARCINOMA

Martti A. Färkkila, Harri Mustonen, Kalle Jokelainen, Johanna Arola, Henrik Alfthan

COMPARISON OF MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY AND ENDOSCOPIC RETROGRADE CHOLANGIOGRAPHY IN DISEASE SEVERITY ASSESSMENT OF PRIMARY SCLEROSING CHOLANGITIS: IMPACT ON PROGNOSIS

Andrea Tenca, Kati Lind, Eila Lantto, Harri Mustonen, Martti A. Färkkila

CORRELATION OF MAGNETIC RESONANCE IMAGING WITH MARKERS OF DISEASE ACTIVITY AND PROGRESSION IN PRIMARY SCLEROSING CHOLANGITIS

Andrea Tenca, Kati Lind, Eila Lantto, Harri Mustonen, Sonja Boyd, Johanna Arola, Martti A. Färkkila

INCREASING THE INFLAMMATORY COMPETENCE OF MACROPHAGES WITH IL-6 OR WITH COMBINATION OF IL-4 AND LPS RESTRAIN THE INVASION OF PANCREATIC CANCER CELLS

Aino Koski, Harri Mustonen, Sanna Vainionpää, Zhanlong Shen, Esko Kemppainen, Hanna Seppänen, Pauli Puolakkainen

PREDICTING THE OUTCOME AFTER DISCONTINUATION OF TNFΑ –BLOCKING AGENTS IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH DEEP REMISSION

Pauliina Molander, Johanna Haapamäki, Kimmo Salminen, Helena Kemppainen, Henna Rautiainen, Urpo Nieminen, Perttu Arkkila, Timo Markus Blomster, Ritva Koskela, Markku Nissinen, Airi Jussila, Juha Kuisma, Jari Punkkinen, Kaija-Leena Kolho, Harri Mustonen, Martti A. Färkkila, Taina Sipponen

SURROGATE MARKERS FOR DISEASE PROGRESSION AND RISK FOR BILIARY NEOPLASIA IN PRIMARY SCLEROSING CHOLANGITIS 

Martti A. Färkkila, Harri Mustonen, Kalle Jokelainen, Johanna Arola, Henrik Alfthan

Item 1 - 6 / 11
1
2